Rational Advisors’s GSK GSK Stock Holding History

Rational Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,580	Closed	-$244K	–	554
2019 Q3	$244K	Hold	4,580	–	–	0.09%	210
2019 Q2	$229K	Sell	4,580 -19,194	-81%	-$963K	0.08%	200
2019 Q1	$1.24M	Buy	23,774 +19,194	+419%	+$959K	0.34%	96
2018 Q4	$219K	Sell	4,580 -7,532	-62%	-$371K	0.07%	173
2018 Q3	$608K	Buy	12,112 +4,640	+62%	+$236K	0.15%	142
2018 Q2	$376K	Hold	7,472	–	–	0.18%	150
2018 Q1	$365K	Sell	7,472 -44,720	-86%	-$2.08M	0.17%	167
2017 Q4	$2.31M	Buy	52,192 +40,000	+328%	+$1.85M	1.2%	6
2017 Q3	$619K	Hold	12,192	–	–	0.33%	96
2017 Q2	$658K	Sell	12,192 -2,448	-17%	-$131K	0.41%	94
2017 Q1	$772K	Buy	+14,640	New	+$743K	0.51%	72
2015 Q3	$1.38M	Hold	28,800	–	–	0.56%	75
2015 Q2	$1.5M	Hold	28,800	–	–	0.48%	76
2015 Q1	$1.66M	Sell	28,800 -8,516	-23%	-$488K	0.4%	90
2014 Q4	$1.99M	Buy	+37,316	New	+$2.09M	0.4%	87
2013 Q4	$4.64M	Sell	69,497 -28,720	-29%	-$1.86M	0.4%	71
2013 Q3	$6.16M	Sell	98,217 -43,619	-31%	-$2.81M	0.47%	40
2013 Q2	$8.86M	Buy	+141,836	New	+$9M	0.74%	14

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Rational Advisors's GSK Position: Q4 2019 in Review

Rational Advisors sold out of GSK (GSK) in Q4 2019, closing a stake of 4,580 shares — an estimated $244K sold.

Rational Advisors first reported a position in GSK in Q2 2013 and held it in 18 quarters. The position peaked at $8.86M in Q2 2013. 895 funds tracked by Wall St. Rank hold GSK as of Q4 2019.

Rational Advisors reported no remaining GSK position as of Q4 2019 after selling out during the quarter.
Rational Advisors sold 4,580 GSK shares in Q4 2019, an estimated $244K.
Rational Advisors first reported a position in GSK in Q2 2013 and held it in 18 quarters.
Rational Advisors's GSK position peaked at $8.86M in Q2 2013.
895 funds tracked by Wall St. Rank held GSK as of Q4 2019.

Based on Rational Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.